Top Markets
Coin of the day
OnKure Therapeutics, Inc. OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKUR
株式のランク #19606
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a... OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
株価
$3.86
最終同期: 2026-08-25
時価総額
$156.32M
変化(1日)
-0.77%
変化(1年)
40.36%
US
取引 OnKure Therapeutics, Inc. (OKUR)

カテゴリー

OnKure Therapeutics, Inc.(OKUR)のEPS
2026 時点のEPS TTM: 0
OnKure Therapeutics, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
OnKure Therapeutics, Inc.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH